Akili, Inc.
AKLIDelisted Jul 2, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001850266
Akili, Inc. was delisted on Jul 2, 2024; its insiders filed their last Form 4 on Jul 8, 2024; 35 institutions reported holding it in 13F filings for Q2 2024, worth $20.4M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Akili, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Akili, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| PureTech Health LLC | 10% Owner | 0Indirect | Jul 8, 2024 | 0 |
| PureTech Health plc | 10% Owner | 0Indirect | Jul 8, 2024 | 0 |
| Palihapitiya Chamath | 10% Owner | 0Indirect | Jul 5, 2024 | 0 |
| SC Master Holdings, LLC | 10% Owner | 0Indirect | Jul 5, 2024 | 0 |
| Temasek Holdings (Private) Ltd | 10% Owner | 0Indirect | Jul 5, 2024 | 0 |
| Fullerton Management Pte Ltd | 10% Owner | 0Indirect | Jul 5, 2024 | 0 |
| Temasek Life Sciences Private Ltd | 10% Owner | 0Indirect | Jul 5, 2024 | 0 |
| TLS Beta Pte. Ltd. | 10% Owner | 0Indirect | Jul 5, 2024 | 0 |
| Studer Jacqueline | Chief Legal Officer | 0 | Jul 2, 2024 | 0 |
| Gazzaley Adam | Director | 0 | Jul 2, 2024 | 0 |
| Martucci Walter Edward II | Director | 0 | Jul 2, 2024 | 0 |
| Franklin Matthew | President & CEO | 0 | Jul 2, 2024 | 0 |
| Spinale John | Director | 0Indirect | Jul 2, 2024 | 0 |
| Shanbhag Santosh | Chief Financial Officer | 392,417 | Dec 8, 2023 | 0 |
| Jones William A Jr | Director | – | May 4, 2023 | 0 |
| Hentges Mary | Director | – | May 4, 2023 | 0 |
| Lemke Christine | Director | – | May 4, 2023 | 0 |
| Ehlert Kenneth | Director | – | May 4, 2023 | 0 |
| SCS Sponsor I LLC | Other: Former Director and 10% Owner | 0 | Aug 23, 2022 | 0 |
| Mehta Kishan | Other: Former Director and 10% Owner | 0 | Aug 23, 2022 | 0 |
| Cowen Aaron | Other: Former Director and 10% Owner | 0 | Aug 23, 2022 | 0 |
| ChaChaCha DNA I, LLC | Other: Former Director and 10% Owner | 0 | Aug 23, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 (view filing) | Sep 11 | 3 daysLate | Studer JacquelineChief Legal Officer | SSale | −1.13K | $1.05 | −$1.19K | −0.3%348.3K after | |
| Sep 14, 2023 (view filing) | Sep 11 | 3 daysLate | Martucci Walter Edward IIChief Executive Officer | SSale | −2.35K | $1.05 | −$2.47K | −0.1%3.15M after | |
| Sep 14, 2023 (view filing) | Sep 11 | 3 daysLate | Franklin MatthewPresident & COO | SSale | −1.73K | $1.05 | −$1.81K | −0.2%753.9K after | |
| Sep 14, 2023 (view filing) | Sep 11 | 3 daysLate | Shanbhag SantoshChief Financial Officer | SSale | −830 | $1.05 | −$871.5 | −0.3%323.6K after |